Bioventus Inc (NASDAQ:BVS)’s traded shares stood at 0.38 million during the last session, with the company’s beta value hitting 0.95. At the close of trading, the stock’s price was $7.34, to imply an increase of 1.10% or $0.08 in intraday trading. The BVS share’s 52-week high remains $14.38, putting it -95.91% down since that peak but still an impressive 46.32% since price per share fell to its 52-week low of $3.94. The company has a valuation of $602.01M, with an average of 0.35 million shares in intraday trading volume over the past 10 days and average of 337.19K shares over the past 3 months.
Analysts have given a consensus recommendation of Hold for Bioventus Inc (BVS), translating to a mean rating of 1.67. Of 3 analyst(s) looking at the stock, 0 analyst(s) give BVS a Sell rating. 0 of those analysts rate the stock as Overweight while 2 advise Hold as 1 recommend it as a Buy.
Bioventus Inc (NASDAQ:BVS) trade information
After registering a 1.10% upside in the last session, Bioventus Inc (BVS) has traded red over the past five days. The 5-day price performance for the stock is -4.05%, and -22.82% over 30 days. With these gigs, the year-to-date price performance is -30.10%. Short interest in Bioventus Inc (NASDAQ:BVS) saw shorts transact 0.78 million shares and set a 2.39 days time to cover.
The extremes give us $2.5 and $12 for target low and target high price respectively. As such, BVS has been trading -63.49% off suggested target high and 65.94% from its likely low.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -113.92% for the past 5-year period. While 2025 is set for a 34.18% return in earnings, projections for the next 5 years are at 16.76% annually.
BVS Dividends
Bioventus Inc has its next earnings report out on 2025-Mar-10. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Bioventus Inc (NASDAQ:BVS)’s Major holders
Bioventus Inc insiders hold 11.48% of total outstanding shares, with institutional holders owning 69.44% of the shares at 78.44% float percentage. In total, 69.44% institutions holds shares in the company, led by ESSEX WOODLANDS MANAGEMENT, INC.. As of 2024-06-30, the company held over 13.02 million shares (or 20.3278% of shares), all amounting to roughly $74.87 million.
The next major institution holding the largest number of shares is JUNIPER INVESTMENT COMPANY, LLC with 6.83 million shares, or about 10.6684% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $39.29 million.
We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF as the top two Mutual Funds with the largest holdings of the Bioventus Inc (BVS) shares. Going by data provided on Dec 31, 2024 , VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 1.03 shares. This is just over 1.56% of the total shares, with a market valuation of $7.57 million. Data from the same date shows that the other fund manager holds a little less at 1.02, or 1.54% of the shares, all valued at about 7.47 million.
